BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doolan DL. Plasmodium immunomics. Int J Parasitol 2011;41:3-20. [PMID: 20816843 DOI: 10.1016/j.ijpara.2010.08.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Thomson-Luque R, Bautista JM. Home Sweet Home: Plasmodium vivax-Infected Reticulocytes-The Younger the Better? Front Cell Infect Microbiol 2021;11:675156. [PMID: 34055670 DOI: 10.3389/fcimb.2021.675156] [Reference Citation Analysis]
2 Tran TM, Samal B, Kirkness E, Crompton PD. Systems immunology of human malaria. Trends Parasitol 2012;28:248-57. [PMID: 22592005 DOI: 10.1016/j.pt.2012.03.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
3 Frimpong A, Kusi KA, Ofori MF, Ndifon W. Novel Strategies for Malaria Vaccine Design. Front Immunol 2018;9:2769. [PMID: 30555463 DOI: 10.3389/fimmu.2018.02769] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
4 Kamali AN, Marín-García P, Azcárate IG, Puyet A, Diez A, Bautista JM. Experimental Immunization Based on Plasmodium Antigens Isolated by Antibody Affinity. J Immunol Res 2015;2015:723946. [PMID: 26539558 DOI: 10.1155/2015/723946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
5 Hosking CG, Driguez P, McWilliam HE, Ilag LL, Gladman S, Li Y, Piedrafita D, McManus DP, Meeusen EN, de Veer MJ. Using the local immune response from the natural buffalo host to generate an antibody fragment library that binds the early larval stages of Schistosoma japonicum. Int J Parasitol 2015;45:729-40. [PMID: 26116907 DOI: 10.1016/j.ijpara.2015.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
6 Longley RJ, Hill AV, Spencer AJ. Malaria vaccines: identifying Plasmodium falciparum liver-stage targets. Front Microbiol 2015;6:965. [PMID: 26441899 DOI: 10.3389/fmicb.2015.00965] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
7 Elliott SR, Fowkes FJ, Richards JS, Reiling L, Drew DR, Beeson JG. Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep 2014;6:100. [PMID: 25580254 DOI: 10.12703/P6-100] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
8 Nahrendorf W, Scholzen A, Sauerwein RW, Langhorne J. Cross-stage immunity for malaria vaccine development. Vaccine 2015;33:7513-7. [PMID: 26469724 DOI: 10.1016/j.vaccine.2015.09.098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
9 Maskus DJ, Bethke S, Seidel M, Kapelski S, Addai-Mensah O, Boes A, Edgü G, Spiegel H, Reimann A, Fischer R, Barth S, Klockenbring T, Fendel R. Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10. Malar J 2015;14:276. [PMID: 26174014 DOI: 10.1186/s12936-015-0797-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
10 Ubillos I, Campo JJ, Jiménez A, Dobaño C. Development of a high-throughput flexible quantitative suspension array assay for IgG against multiple Plasmodium falciparum antigens. Malar J 2018;17:216. [PMID: 29843713 DOI: 10.1186/s12936-018-2365-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
11 Kucharska I, Thai E, Srivastava A, Rubinstein JL, Pomès R, Julien JP. Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11. Elife 2020;9:e59018. [PMID: 33253113 DOI: 10.7554/eLife.59018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang Y, Yao Y, Du W, Wu K, Xu W, Lin M, Tan H, Li J. Development of loop-mediated isothermal amplification with Plasmodium falciparum unique genes for molecular diagnosis of human malaria. Pathog Glob Health 2017;111:247-55. [PMID: 28683669 DOI: 10.1080/20477724.2017.1347379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
13 Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL. Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clin Cancer Res 2018;24:1305-14. [PMID: 29301829 DOI: 10.1158/1078-0432.CCR-17-1929] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 6.8] [Reference Citation Analysis]
14 Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, Baldi P, Felgner PL, Doolan DL. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics 2011;10:M111.007948. [PMID: 21628511 DOI: 10.1074/mcp.M111.007948] [Cited by in Crossref: 101] [Cited by in F6Publishing: 74] [Article Influence: 9.2] [Reference Citation Analysis]
15 Davies DH, Duffy P, Bodmer JL, Felgner PL, Doolan DL. Large screen approaches to identify novel malaria vaccine candidates. Vaccine 2015;33:7496-505. [PMID: 26428458 DOI: 10.1016/j.vaccine.2015.09.059] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
16 Kassegne K, Abe EM, Chen J, Zhou X. Immunomic approaches for antigen discovery of human parasites. Expert Review of Proteomics 2016;13:1091-101. [DOI: 10.1080/14789450.2016.1252675] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
17 Imboumy-Limoukou RK, Oyegue-Liabagui SL, Ndidi S, Pegha-Moukandja I, Kouna CL, Galaway F, Florent I, Lekana-Douki JB. Comparative Antibody Responses Against three Antimalarial Vaccine Candidate Antigens from Urban and Rural Exposed Individuals in Gabon. Eur J Microbiol Immunol (Bp) 2016;6:287-97. [PMID: 27980857 DOI: 10.1556/1886.2016.00027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Powles L, Xiang SD, Selomulya C, Plebanski M. The Use of Synthetic Carriers in Malaria Vaccine Design. Vaccines (Basel) 2015;3:894-929. [PMID: 26529028 DOI: 10.3390/vaccines3040894] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
19 Douradinha B, Doolan DL. Harnessing immune responses against Plasmodium for rational vaccine design. Trends Parasitol 2011;27:274-83. [PMID: 21531627 DOI: 10.1016/j.pt.2011.01.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
20 Ubillos I, Aguilar R, Sanz H, Jiménez A, Vidal M, Valmaseda A, Dong Y, Gaur D, Chitnis CE, Dutta S, Angov E, Aponte JJ, Campo JJ, Valim C, Harezlak J, Dobaño C. Analysis of factors affecting the variability of a quantitative suspension bead array assay measuring IgG to multiple Plasmodium antigens. PLoS One 2018;13:e0199278. [PMID: 29966018 DOI: 10.1371/journal.pone.0199278] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
21 Shivam S, El-Matbouli M, Kumar G. Development of Fish Parasite Vaccines in the OMICs Era: Progress and Opportunities. Vaccines (Basel) 2021;9:179. [PMID: 33672552 DOI: 10.3390/vaccines9020179] [Reference Citation Analysis]
22 Carmona SJ, Nielsen M, Schafer-Nielsen C, Mucci J, Altcheh J, Balouz V, Tekiel V, Frasch AC, Campetella O, Buscaglia CA, Agüero F. Towards High-throughput Immunomics for Infectious Diseases: Use of Next-generation Peptide Microarrays for Rapid Discovery and Mapping of Antigenic Determinants. Mol Cell Proteomics 2015;14:1871-84. [PMID: 25922409 DOI: 10.1074/mcp.M114.045906] [Cited by in Crossref: 61] [Cited by in F6Publishing: 34] [Article Influence: 8.7] [Reference Citation Analysis]
23 Goodswen SJ, Kennedy PJ, Ellis JT. A Gene-Based Positive Selection Detection Approach to Identify Vaccine Candidates Using Toxoplasma gondii as a Test Case Protozoan Pathogen. Front Genet 2018;9:332. [PMID: 30177953 DOI: 10.3389/fgene.2018.00332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Liu Z, Jarrett RF, Hjalgrim H, Proietti C, Chang ET, Smedby KE, Yu KJ, Lake A, Troy S, McAulay KA, Pfeiffer RM, Adami HO, Glimelius B, Melbye M, Hildesheim A, Doolan DL, Coghill AE. Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma. Int J Cancer 2020;147:608-18. [PMID: 31618442 DOI: 10.1002/ijc.32741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Panda SK, Mahapatra RK. In-silico screening, identification and validation of a novel vaccine candidate in the fight against Plasmodium falciparum. Parasitol Res 2017;116:1293-305. [DOI: 10.1007/s00436-017-5408-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
26 Driguez P, McManus DP, Gobert GN. Clinical implications of recent findings in schistosome proteomics. Expert Rev Proteomics 2016;13:19-33. [PMID: 26558506 DOI: 10.1586/14789450.2016.1116390] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
27 Heide J, Vaughan KC, Sette A, Jacobs T, Schulze Zur Wiesch J. Comprehensive Review of Human Plasmodium falciparum-Specific CD8+ T Cell Epitopes. Front Immunol 2019;10:397. [PMID: 30949162 DOI: 10.3389/fimmu.2019.00397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 McWilliam HE, Driguez P, Piedrafita D, McManus DP, Meeusen EN. Novel immunomic technologies for schistosome vaccine development. Parasite Immunol 2012;34:276-84. [PMID: 22486551 DOI: 10.1111/j.1365-3024.2011.01330.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
29 Loiseau C, Cooper MM, Doolan DL. Deciphering host immunity to malaria using systems immunology. Immunol Rev 2020;293:115-43. [PMID: 31608461 DOI: 10.1111/imr.12814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
30 Hickey BW, Lumsden JM, Reyes S, Sedegah M, Hollingdale MR, Freilich DA, Luke TC, Charoenvit Y, Goh LM, Berzins MP, Bebris L, Sacci JB Jr, De La Vega P, Wang R, Ganeshan H, Abot EN, Carucci DJ, Doolan DL, Brice GT, Kumar A, Aguiar J, Nutman TB, Leitman SF, Hoffman SL, Epstein JE, Richie TL. Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity. Malar J 2016;15:377. [PMID: 27448805 DOI: 10.1186/s12936-016-1435-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
31 Adame-Gallegos JR, Shi J, McIntosh RS, Pleass RJ. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)). Exp Parasitol 2012;130:384-93. [PMID: 22343045 DOI: 10.1016/j.exppara.2012.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
32 Mueller I, Galinski MR, Tsuboi T, Arevalo-Herrera M, Collins WE, King CL. Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets. Adv Parasitol 2013;81:77-131. [PMID: 23384622 DOI: 10.1016/B978-0-12-407826-0.00003-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 48] [Article Influence: 7.4] [Reference Citation Analysis]
33 Fan Y, Wang Y, Ju C, Zhang T, Xu B, Hu W, Chen J. Systematic analysis of natural antibody responses to P. falciparum merozoite antigens by protein arrays. Journal of Proteomics 2013;78:148-58. [DOI: 10.1016/j.jprot.2012.11.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
34 Koram KA. Antibodies to Plasmodium falciparum antigens and the risk of clinical malaria in endemic populations. Expert Rev Anti Infect Ther 2011;9:987-91. [PMID: 22029518 DOI: 10.1586/eri.11.128] [Reference Citation Analysis]
35 Skinner-adams TS, Sumanadasa SD, Fisher GM, Davis RA, Doolan DL, Andrews KT. Defining the targets of antiparasitic compounds. Drug Discovery Today 2016;21:725-39. [DOI: 10.1016/j.drudis.2016.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
36 Cardoso FC, Roddick JS, Groves P, Doolan DL. Evaluation of approaches to identify the targets of cellular immunity on a proteome-wide scale. PLoS One 2011;6:e27666. [PMID: 22096610 DOI: 10.1371/journal.pone.0027666] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
37 Holtfreter S, Kolata J, Stentzel S, Bauerfeind S, Schmidt F, Sundaramoorthy N, Bröker BM. Omics Approaches for the Study of Adaptive Immunity to Staphylococcus aureus and the Selection of Vaccine Candidates. Proteomes 2016;4:E11. [PMID: 28248221 DOI: 10.3390/proteomes4010011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
38 Nyasa RB, Kimbi HK, Zofou D, DeBarry JD, Kissinger JC, Titanji VP. An evolutionary approach to identify potentially protective B cell epitopes involved in naturally acquired immunity to malaria and the role of EBA-175 in protection amongst denizens of Bolifamba, Cameroon. Malar J 2016;15:281. [PMID: 27207101 DOI: 10.1186/s12936-016-1337-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Campo JJ, Aponte JJ, Skinner J, Nakajima R, Molina DM, Liang L, Sacarlal J, Alonso PL, Crompton PD, Felgner PL, Dobaño C. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites. Mol Cell Proteomics 2015;14:519-31. [PMID: 25547414 DOI: 10.1074/mcp.M114.044677] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
40 Schuldt NJ, Amalfitano A. Malaria vaccines: focus on adenovirus based vectors. Vaccine 2012;30:5191-8. [PMID: 22683663 DOI: 10.1016/j.vaccine.2012.05.048] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
41 Schussek S, Trieu A, Apte SH, Sidney J, Sette A, Doolan DL. Novel Plasmodium antigens identified via genome-based antibody screen induce protection associated with polyfunctional T cell responses. Sci Rep 2017;7:15053. [PMID: 29118376 DOI: 10.1038/s41598-017-15354-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
42 Portugal S, Pierce SK, Crompton PD. Young lives lost as B cells falter: what we are learning about antibody responses in malaria. J Immunol 2013;190:3039-46. [PMID: 23526829 DOI: 10.4049/jimmunol.1203067] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 8.9] [Reference Citation Analysis]
43 Li J, Han E. Dissection of the Plasmodium vivax reticulocyte binding-like proteins (PvRBPs). Biochemical and Biophysical Research Communications 2012;426:1-6. [DOI: 10.1016/j.bbrc.2012.08.055] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
44 Wang D, Li Y, Liu Y, He Y, Shi G. Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity. PLoS One 2016;11:e0146805. [PMID: 26760041 DOI: 10.1371/journal.pone.0146805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Doolan DL, Apte SH, Proietti C. Genome-based vaccine design: the promise for malaria and other infectious diseases. Int J Parasitol 2014;44:901-13. [PMID: 25196370 DOI: 10.1016/j.ijpara.2014.07.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
46 Baum E, Badu K, Molina DM, Liang X, Felgner PL, Yan G. Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenyan highland sites with differing transmission levels. PLoS One 2013;8:e82246. [PMID: 24312649 DOI: 10.1371/journal.pone.0082246] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
47 Cai J, Chen S, Zhu F, Lu X, Liu T, Xu W. Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria? Front Microbiol 2021;12:670775. [PMID: 33995336 DOI: 10.3389/fmicb.2021.670775] [Reference Citation Analysis]
48 Julien J, Wardemann H. Antibodies against Plasmodium falciparum malaria at the molecular level. Nat Rev Immunol 2019;19:761-75. [DOI: 10.1038/s41577-019-0209-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
49 Bautista JM, Marín-García P, Diez A, Azcárate IG, Puyet A. Malaria proteomics: insights into the parasite-host interactions in the pathogenic space. J Proteomics 2014;97:107-25. [PMID: 24140976 DOI: 10.1016/j.jprot.2013.10.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
50 Lustigman S. Current Approaches to the Development of a Vaccine Against Filarial Nematodes. In: Lamb TJ, editor. Immunity to Parasitic Infection. Chichester: John Wiley & Sons, Ltd; 2012. pp. 459-70. [DOI: 10.1002/9781118393321.ch28] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Kuleš J, Horvatić A, Guillemin N, Galan A, Mrljak V, Bhide M. New approaches and omics tools for mining of vaccine candidates against vector-borne diseases. Mol Biosyst 2016;12:2680-94. [PMID: 27384976 DOI: 10.1039/c6mb00268d] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
52 De Sousa KP, Doolan DL. Immunomics: a 21st century approach to vaccine development for complex pathogens. Parasitology 2016;143:236-44. [PMID: 26864136 DOI: 10.1017/S0031182015001079] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
53 Fenta M, Kahaliw W. Evaluation of Antimalarial Activity of Hydromethanolic Crude Extract and Solvent Fractions of the Leaves of Nuxia congesta R. Br. Ex Fresen (Buddlejaceae) in Plasmodium berghei Infected Mice. J Exp Pharmacol 2019;11:121-34. [PMID: 31908546 DOI: 10.2147/JEP.S230636] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Schussek S, Trieu A, Doolan DL. Genome- and proteome-wide screening strategies for antigen discovery and immunogen design. Biotechnology Advances 2014;32:403-14. [DOI: 10.1016/j.biotechadv.2013.12.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
55 Craig AG, Grau GE, Janse C, Kazura JW, Milner D, Barnwell JW, Turner G, Langhorne J; participants of the Hinxton Retreat meeting on Animal Models for Research on Severe Malaria. The role of animal models for research on severe malaria. PLoS Pathog 2012;8:e1002401. [PMID: 22319438 DOI: 10.1371/journal.ppat.1002401] [Cited by in Crossref: 196] [Cited by in F6Publishing: 188] [Article Influence: 19.6] [Reference Citation Analysis]
56 Greenwood BM, Targett GA. Malaria vaccines and the new malaria agenda. Clin Microbiol Infect 2011;17:1600-7. [PMID: 21883665 DOI: 10.1111/j.1469-0691.2011.03612.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
57 Bueno LL, Lobo FP, Morais CG, Mourão LC, de Ávila RA, Soares IS, Fontes CJ, Lacerda MV, Chavez Olórtegui C, Bartholomeu DC, Fujiwara RT, Braga EM. Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1). PLoS One 2011;6:e21289. [PMID: 21713006 DOI: 10.1371/journal.pone.0021289] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
58 Khan N, Kumar R, Chauhan S, Farooq U. An immunoinformatics approach to promiscuous peptide design for the Plasmodium falciparum erythrocyte membrane protein-1. Mol Biosyst 2017;13:2160-7. [PMID: 28856362 DOI: 10.1039/c7mb00332c] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Chia WN, Goh YS, Rénia L. Novel approaches to identify protective malaria vaccine candidates. Front Microbiol 2014;5:586. [PMID: 25452745 DOI: 10.3389/fmicb.2014.00586] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
60 Davies DH, Chun S, Hermanson G, Tucker JA, Jain A, Nakajima R, Pablo J, Felgner PL, Liang X. T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association. J Immunol 2014;193:1812-27. [PMID: 25024392 DOI: 10.4049/jimmunol.1400663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
61 Shepherd SM, Shoff WH. Immunization in travel medicine. Prim Care 2011;38:643-79, viii. [PMID: 22094138 DOI: 10.1016/j.pop.2011.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Chen JH, Zhang T, Ju C, Xu B, Lu Y, Mo XJ, Chen SB, Fan YT, Hu W, Zhou XN. An integrated immunoproteomics and bioinformatics approach for the analysis of Schistosoma japonicum tegument proteins. J Proteomics 2014;98:289-99. [PMID: 24448400 DOI: 10.1016/j.jprot.2014.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
63 Swain MT, Larkin DM, Caffrey CR, Davies SJ, Loukas A, Skelly PJ, Hoffmann KF. Schistosoma comparative genomics: integrating genome structure, parasite biology and anthelmintic discovery. Trends Parasitol 2011;27:555-64. [PMID: 22024648 DOI: 10.1016/j.pt.2011.09.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
64 Berry AA, Obiero JM, Travassos MA, Ouattara A, Coulibaly D, Adams M, de Assis RR, Jain A, Taghavian O, Sy A, Nakajima R, Jasinskas A, Laurens MB, Takala-Harrison S, Kouriba B, Kone AK, Doumbo OK, Sim BKL, Hoffman SL, Plowe CV, Thera MA, Felgner PL, Lyke KE. Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome. NPJ Vaccines 2021;6:115. [PMID: 34518543 DOI: 10.1038/s41541-021-00363-y] [Reference Citation Analysis]
65 Proietti C, Doolan DL. The case for a rational genome-based vaccine against malaria. Front Microbiol 2014;5:741. [PMID: 25657640 DOI: 10.3389/fmicb.2014.00741] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
66 McWilliam HE, Driguez P, Piedrafita D, McManus DP, Meeusen EN. Discovery of novel Schistosoma japonicum antigens using a targeted protein microarray approach. Parasit Vectors 2014;7:290. [PMID: 24964958 DOI: 10.1186/1756-3305-7-290] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
67 Obiero JM, Campo JJ, Scholzen A, Randall A, Bijker EM, Roestenberg M, Hermsen CC, Teng A, Jain A, Davies DH, Sauerwein RW, Felgner PL. Antibody Biomarkers Associated with Sterile Protection Induced by Controlled Human Malaria Infection under Chloroquine Prophylaxis. mSphere 2019;4:e00027-19. [PMID: 30787114 DOI: 10.1128/mSphereDirect.00027-19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
68 Liu Z, Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Yu KJ, Lou PJ, Wang CP, Mulvenna J, Middeldorp JM, Bethony J, Chen CJ, Doolan DL, Hildesheim A. Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome. J Infect Dis 2018;217:1923-31. [PMID: 29509907 DOI: 10.1093/infdis/jiy122] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
69 Mo J, Li J. In silico analysis for structure, function and T-cell epitopes of a hypothetical conserved (HP-C) protein coded by PVX_092425 in Plasmodium vivax. Pathog Glob Health 2015;109:61-7. [PMID: 25706099 DOI: 10.1179/2047773215Y.0000000005] [Reference Citation Analysis]
70 Riley EM, Stewart VA. Immune mechanisms in malaria: new insights in vaccine development. Nat Med 2013;19:168-78. [DOI: 10.1038/nm.3083] [Cited by in Crossref: 133] [Cited by in F6Publishing: 125] [Article Influence: 14.8] [Reference Citation Analysis]